Harrow Health Inc.

(HROW) Trade

By |

Profile

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.

Contact Information

Website: www.imprimisrx.com
Email: ir@imprimispharma.com
Main Phone: +1 858 704-4040
Address: 12264 EI Camino Real
Address 2: Suite 350
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSC
CEO: Mark L. Baum
Employees: 134
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.

Contact Information

Website: www.imprimisrx.com
Email: ir@imprimispharma.com
Main Phone: +1 858 704-4040
Address: 12264 EI Camino Real
Address 2: Suite 350
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSC
CEO: Mark L. Baum
Employees: 134
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.94 $ 0.05 (0.85%)
Last Price 5.94 Change $ 0.05 Change % 0.85 Tick N/A
Bid 4.51 Bid Size 400.00 Ask 12.31 Ask Size 100.00
Open 5.90 High 6.03 Low 5.82 Prev Close 5.89
Last Trade Volume 191,507 52 Wk Hi 8.99 52 Wk Low 2.22
Market Cap 149.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,165,965.00 EPS (TTM) 0.99 PE Ratio 5.90 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 7
Number of Buys 0 2
Number of Sells 3 5
Net Activity -30000 -110000
Last 10 Buys Shares
Richard L. Lindstrom 1,000
Mark L. Baum 1,000
Andrew R. Boll 1,000
Last 10 Sell Shares
Robert J. Kammer 1,000
Robert J. Kammer 1,000
Robert J. Kammer 1,000
Robert J. Kammer 1,000
Robert J. Kammer 1,000
Robert J. Kammer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 11.5 11.5 5 11.5
Low Target Price Estimate 10 10 5 10
Mean Target Price Estimate 10.75 10.75 5 10.75
Standard Deviation 1.06 1.06 0 1.06
Date of Most Recent Estimate 12/13/18 12/13/18 05/11/17 12/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 0 0 0